Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Banavara L. Mylari"'
Autor:
Banavara L. Mylari, Peter J. Oates, Charles Kilo, Kathy Chang, Yasudo Ido, Jens R. Nyengaard, Ronald G. Tilton, Joseph R. Williamson
Publikováno v:
Ido, Y, Nyengaard, J R, Chang, K, Tilton, R G, Kilo, C, Mylari, B L, Oates, P J & Williamson, J R 2010, ' Early neural and vascular dysfunctions in diabetic rats are largely sequelae of increased sorbitol oxidation ', Antioxidants and Redox Signaling, vol. 12, no. 1, pp. 39-51 . https://doi.org/10.1089/ars.2009.2502
These experiments were undertaken to assess the importance of cytoplasmic (c) sorbitol oxidation versus mitochondrial (m) pyruvate oxidation in mediating neural and vascular dysfunction attributable to hyperglycemia in diabetic rats. Increased oxidat
Autor:
William H. Martin, Banavara L. Mylari, Peter J. Oates, James B. Coutcher, Michael C. Linhares, David A. Tess, Michael S. Dina, David A. Beebe, Gregory J. Withbroe, Sandra J Armento, Melissa O'Gorman, William James Zembrowski, Edward L. Conn
Publikováno v:
Journal of Medicinal Chemistry. 48:6326-6339
Discovery of a highly selective, potent, and safe non-carboxylic acid, non-hydantoin inhibitor of aldose reductase (AR) capable of potently blocking the excess glucose flux through the polyol pathway that prevails under diabetic conditions has been a
Autor:
Peter J. Oates, Banavara L. Mylari
Publikováno v:
Expert Opinion on Investigational Drugs. 8:2095-2119
The 'late complications' of diabetes mellitus, i.e., nephropathy, neuropathy and retinopathy are firmly rooted in inadequate control of blood glucose: hyperglycaemia. Hyperglycaemia causes elevated cytosolic glucose and/or rates of glucose metabolism
Publikováno v:
ChemInform. 22
Ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate (1, EBPC) is a potent and specific inhibitor of aldose reductase. It was greater than 4000X more potent in its inhibition of rat lens aldose reductase than the closely related rat or pig kidney
Publikováno v:
ChemInform. 22
A series of 1,2-dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine, 1,2-dihydro-1-oxopyrrolo[3,2,1-kl]phenoxazine, and 1,2-dihydro-1-oxopyrrolo[3,2,1-de]acridine-2-carboxamides were prepared by reaction of 1,2-dihydro-1-oxo-pyrrolo[3,2,1-kl]phenothiazine or
Autor:
Charles E. Aldinger, Todd W. Siegel, Larson Eric R, Thomas A. Beyer, Michael F. Dee, Banavara L. Mylari, David H. Singleton, William James Zembrowski
Publikováno v:
ChemInform. 22
A new working hypothesis that there is a hitherto unrecognized binding site on the aldose reductase (AR) enzyme with strong affinity for benzothiazoles was pursued for the design of novel, potent aldose reductase inhibitors (ARIs). The first applicat
Autor:
Michael S. Dina, Nathaniel S. Brackett, Peter J. Oates, James B. Coutcher, William James Zembrowski, Banavara L. Mylari, David A. Beebe
Publikováno v:
ChemInform. 32
We report here on our medicinal chemistry and pharmacology efforts to provide a potent sorbitol dehydrogenase inhibitor (SDI) as a tool to probe a recently disclosed hypothesis centered on the role of sorbitol dehydrogenase (SDH) in the second step o
Autor:
Todd W. Siegel, Thomas A. Beyer, William James Zembrowski, Banavara L. Mylari, Charles E. Aldinger
Publikováno v:
Journal of Medicinal Chemistry. 35:2155-2162
Benzothiazole side chains featured in zopolrestat (1a) and its congeners were incorporated into oxophthalazineacetic acid replacements, including indazole, pyridazinone, and pyridopyridazinone with a pendant acetic acid moiety. Potent aldose reductas
Autor:
Thomas A. Beyer, William James Zembrowski, Todd W. Siegel, Charles E. Aldinger, Michael F. Dee, Pamela J. Scott, Banavara L. Mylari
Publikováno v:
Journal of Medicinal Chemistry. 35:457-465
A broad structure-activity program was undertaken in search of effective surrogates for the key benzothiazole side chain of the potent aldose reductase inhibitor, zopolrestat (1). A structure-driven approach was pursued, which spanned exploration of
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 29:143-148
Synthesis of the title compound, C14 labeled CP-73,850 (zopolrestat), was accomplished by condensation of 1-phthalazineacetic acid, 3,-14C cyanomethyl-3,4-dihydro-4-oxo-, ethyl ester with 3-amino-4-mercapto-benzotrifluoride, followed by base hydrolys